Argos Therapeutics Appoints Robert F. Carey To Board
This article was originally published in Scrip
Executive Summary
Robert F. Carey, who is currently executive vice-president and chief business officer for Horizon Pharma Plc., has been named to Argos Therapeutics' board of directors. Carey has over 30 years' experience in healthcare investment banking, business development and investor relations and was also responsible for initiating and managing JMP Securities' healthcare group.